Spherusol (Nielsen BioSciences, Inc.)


Welcome to the PulseAid listing for the Spherusol drug offered from Nielsen BioSciences, Inc.. This Skin Test Antigen [EPC],Cell-mediated Immunity [PE],Antigens, Fungal [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Nielsen BioSciences, Inc.
NON-PROPRIETARY NAME: Coccidioides immitis Spherule-Derived Skin Test Antigen
SUBSTANCE NAME: COCCIDIOIDES IMMITIS SPHERULE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Skin Test Antigen [EPC],Cell-mediated Immunity [PE],Antigens, Fungal [Chemical/Ingredient]
ROUTE: INTRADERMAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2011-07-29
END MARKETING DATE: 0000-00-00


Spherusol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSpherusol from Nielsen BioSciences, Inc.
LABELER NAME: Nielsen BioSciences, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 12.7(ug/mL)
START MARKETING DATE: 2011-07-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59584-140_04f0d499-26c5-1d4c-e054-00144ff88e88
PRODUCT NDC: 59584-140
APPLICATION NUMBER: BLA125354

Other COCCIDIOIDES IMMITIS SPHERULE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Nielsen BioSciences, Inc.Spherusol